(Image credit: Jorge Vasconez/Unsplash.)
Manulife Financial Corporation (Toronto) announced today that it has entered into a $5.4 billion1 reinsurance agreement with Reinsurance Group of America (RGA; Chesterfield, Mo.), including $2.4 billion of long-term care (“LTC”) reserves.
Manulife identifies highlights of its transaction with RGA as follows:
- Reinsuring $2.4 billion of LTC reserves to RGA on a full risk transfer basis
- Inclusive of our previous LTC reinsurance transaction2 (“previous transaction”), upon closing we will have cumulatively reduced LTC reserves by 18% and LTC morbidity sensitivity by 17%3
- Transacted LTC block is younger, with a greater proportion of active life reserves than our previous transaction
- Modest negative 4% LTC cede4 further validates our reserves and assumptions
- Transaction also includes a legacy block of U.S. structured settlements with $3.0 billion of reserves
- Accretive to core ROE5, and an attractive core earnings5 multiple of 11.4 times6; neutral impact to core EPS5
- Close to 1.0x book value7; expect to release $0.8 billion of capital, which we intend to fully return to shareholders
- Expect to dispose $1.5 billion of alternative long-duration assets (“ALDA”)
“We are further unlocking significant shareholder value with a second milestone LTC reinsurance transaction within 12 months, which accelerates our transformation to reshape our portfolio towards higher return and lower risk,” comments Roy Gori, President & CEO, Manulife. “This transaction further demonstrates our ability to execute on complex transactions and collaborate with experienced counterparties to deliver win-win outcomes, including on both mature and younger LTC blocks. The deal is priced at 11.4 times core earnings multiple and is expected to be accretive to core ROE after we return the released capital to shareholders through share buybacks.”
“Together with our previously completed LTC transaction, we will have cumulatively reduced our LTC reserves by 18 percent within a year, upon closing, meaningfully improving the return profile of our inforce business,” comments Marc Costantini, Global Head of Strategy and Inforce Management, Manulife. “The pricing of this transaction further validates our prudent LTC reserves and assumptions. There continues to be attractive opportunities to generate shareholder value through organic LTC optimization, and we remain open to further inorganic opportunities.”
Transaction Summary
Manulife says it will reinsure a combined $5.4 billion of reserves across two blocks of legacy business to RGA. The blocks include portions of U.S. LTC and U.S. structured settlements. The LTC block represents $2.4 billion, or 6 percent of Manulife’s total LTC reserves as of September 30, 2024. The transaction is priced at close to 1.0 times book value, reflecting a modest negative ceding commission on LTC, and a nominal ceding commission on the structured settlements block.
Manulife calls RGA a highly experienced global reinsurer with whom the Canadian company holds multiple existing reinsurance arrangements. Manulife reports that the transaction includes significant structural protections, including over-collateralized trusts to hold investment assets. The reinsurance represents a 75 percent quota share on both ceded blocks.
In connection with the transaction, Manulife says it expects to dispose $1.5 billion of ALDA. Manulife adds that it will continue to administer all reinsured policies for a seamless customer service experience. The transaction is expected to close in early 2025, subject to customary closing conditions.
Manulife asserts that transacting on a younger LTC block further validates LTC reserves and assumptions. The company says the transaction with RGA will reduce LTC reserves by $2.4 billion, or 6 percent, and is expected to reduce the underlying LTC reserve sensitivity to changes in morbidity assumptions by 7 percent. The transaction represents a full risk transfer on a younger LTC block, which has similar characteristics to our retained LTC blocks, with a greater proportion of active life reserves than the ceded block in Manulife’s previous LTC reinsurance transaction.
Including Manulife’s previous LTC reinsurance transaction, which closed in February 2024, the company will have cumulatively reduced LTC reserves and morbidity sensitivity by 18 percent and 17 percent, respectively, upon closing. This demonstrates our proven ability to transact on both mature and younger LTC blocks.
“The modest negative ceding commission on the LTC block of 4 percent of IFRS reserves further validates our LTC reserves and assumptions,” a Manulife statement says.
Unlocking Value for Shareholders
Manulife expects the transaction to release $0.8 billion of capital, which the firm says it intends to fully return to shareholders through common share buybacks post-closing. “We are committed to repurchasing for cancellation the full 90 million common shares allowed under our current NCIB program, which expires in February 2025,” the Manulife statement says. “Further buybacks beyond the 90 million shares common shares allowed under our current NCIB program will require a new NCIB program, which will be subject to the approval of the Office of the Superintendent of Financial Institutions [OSFI] and the Toronto Stock Exchange [TSX].”
The transaction is priced at close to 1.0 times book value and is expected to result in an annual reduction to core earnings and net income attributed to shareholders of $70 million and $50 million, respectively. With a capital release of $0.8 billion, the transaction represents a deal multiple of 11.4 times core earnings. The transaction is expected to be accretive to core ROE, and have a neutral impact on core EPS, after the impact of expected share buybacks.


